Top Markets
Coin of the day
AB Science S.A. AB Science S.A.

AB Science S.A.

AB
Ранг среди акций #24476
AB Science S.A. is a pharmaceutical company dedicated to the discovery,... AB Science S.A. is a pharmaceutical company dedicated to the discovery, development, and commercialization of protein kinase inhibitors for applications in both human and animal health. Its primary drug candidate, masitinib, a tyrosine kinase inhibitor, is currently undergoing late-stage (Phase III) clinical investigations for a range of serious conditions including prostate cancer, pancreatic cancer, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Alzheimer's disease, severe asthma, and mastocytosis. Additionally, masitinib is being evaluated in Phase II clinical trials for the treatment of Covid-19. The company's pipeline also features AB8939, a synthetic microtubule destabilizer aimed at treating acute myeloid leukemia, and AB20001, which is in Phase 2 trials to assess the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients experiencing moderate to severe COVID-19. Masitinib is sold under the brand name Masivet in the European market. AB Science S.A. was founded in 2001 and is based in Paris, France.
Цена акции
$0.82200553
Рыночная капитализация
$60.21M
Изменение (1 день)
0.00%
Изменение (1 год)
-45.55%
Страна
FR
Торговля AB Science S.A. (AB)

Категория

История цены акций AB Science S.A. (AB)
Наивысшая цена закрытия: $0.89 2026-08-01

Наименьшая цена закрытия: $16.75 2010-04-01
История цены акций AB Science S.A. с 2010 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -8.97%
2025 63.64%
2024 -74.78%
2023 -54.37%
2022 -42.31%
2021 -20.56%
2020 194.79%
2019 39.37%
2018 -58.53%
2017 -24.07%
2016 -8.24%
2015 -2.05%
2014 -27.26%
2013 -13.13%
2012 239.91%
2011 -35.27%
2010 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$171.67 -
DE
$163.63 27.51%
DE
$37.61 23.06%
JP
$223.11 32.17%
CH
$20.99 11.74%
IN